Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
9,772,625
-
Share change
-
+1,356,378
-
Total reported value
-
$18,275,141
-
Put/Call ratio
-
639%
-
Price per share
-
$1.87
-
Number of holders
-
27
-
Value change
-
+$2,408,132
-
Number of buys
-
8
-
Number of sells
-
12
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2024
As of 30 Jun 2024,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,772,625 shares.
The largest 10 holders included
Long Focus Capital Management, LLC, Capital International Investors, UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO, PRINCIPAL FINANCIAL GROUP INC, MACQUARIE GROUP LTD, KBC Group NV, LPL Financial LLC, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.